Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6280996 | 0.98 | BACE1 (0.32) | — | |
| Methyl Alcohol SCHEMBL28491792 | 0.95 | BACE1 (0.31) | — | |
| Hydrogen Peroxide SCHEMBL3487883 | 0.95 | BACE1 (0.31) | — | |
| Phosphine SCHEMBL28250968 | 0.95 | — | — | |
| SCHEMBL8637088 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL28815279 | 0.95 | — | — | |
| SCHEMBL6474891 | 0.95 | — | — | |
| SCHEMBL22157240 | 0.95 | — | — | |
| Bromide SCHEMBL21404082 | 0.95 | — | — | |
| SCHEMBL28029843 | 0.95 | BACE1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120004697-A | Preparation method of OrgVO material and application of OrgVO material as secondary battery anode material | 同济大学 | 2025-05-16 | — | — | CN | claimed |
| US-12102617-B2 | Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2024-10-01 | — | — | US | claimed |
| US-20220387390-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING A SYNERGISTIC COMBINATION OF ACTIVATED CREATININE AND AN IMIDAZOLE ANTIFUNGAL AGENT | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2022-12-08 | — | — | US | claimed |
| US-11351153-B2 | Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2022-06-07 | — | — | US | claimed |
| US-11058655-B2 | Compositions and methods for treatment of inflammation | VIREO SYSTEMS, INC. (US) | 2021-07-13 | — | — | US | claimed |
| CN-112057673-A | Preparation method of poly-L-lactic acid tissue filler | 尹振宇 | 2020-12-11 | — | — | CN | claimed |
| CN-111888523-A | Preparation method of polylactic acid gel for improving skin | 尹振宇 | 2020-11-06 | — | — | CN | claimed |
| US-20200197343-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION | VIREO SYSTEMS, INC. (US) | 2020-06-25 | — | — | US | claimed |
| CN-109134380-A | Chloro aminooimidazole class compound and preparation method thereof, purposes and detection method | 上海慈瑞医药科技股份有限公司 | 2019-01-04 | — | — | CN | claimed |
| US-20180250255-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION | VIREO SYSTEMS, INC. (US) | 2018-09-06 | — | — | US | claimed |
| CN-104119518-A | Method for synthesizing poly(butanediol succinate-co-butanediol adipate) (PBSA) by biological organic guanidine salt catalysis process | NANJING UNIVERSITY OF TECHNOLOGY | 2014-10-29 | — | — | CN | claimed |
| CN-102504214-B | Process method for catalytic synthesis of poly lactic acid-glycolic acid by using bionic organic guanidinium | NANJING UNIVERSITY OF TECHNOLOGY | 2013-12-11 | — | — | CN | claimed |
| CN-102504214-A | Process method for catalytic synthesis of poly lactic acid-glycolic acid by using bionic organic guanidinium | NANJING UNIVERSITY OF TECHNOLOGY | 2012-06-20 | — | — | CN | claimed |
| EP-2059518-B1 | SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF | NOVARTIS AG (CH) | 2011-04-06 | — | — | EP | claimed |
| US-20100284954-A1 | PROCESS FOR RELAXING KERATIN FIBRES | L'OREAL (FR) | 2010-11-11 | — | — | US | claimed |
| US-20100168060-A1 | SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF | NOVARTIS AG (CH) | 2010-07-01 | — | — | US | claimed |
| EP-2059518-A2 | SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF | Novartis AG (CH) | 2009-05-20 | — | — | EP | claimed |
| WO-2008027523-A2 | SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF | NOVARTIS AG (CH) | 2008-03-06 | — | — | WO | claimed |
| US-20060127337-A1 | Process for relaxing keratin fibres | L'OREAL (FR) | 2006-06-15 | — | — | US | claimed |
| US-6333332-B1 | STORAGE STABILITY | IMPAX LABORATORIES, INC. | 2001-12-25 | — | — | US | claimed |